Thx @cafa , agree was not expecting impact from SARAH results but looking if growth in dose sales had improved to get some sense if Sirtex is holding or growing market share in the segments it currently competes in.
The question in my mind is are we losing potential business to BTG/TheraSphere or Lonsurf?
Also can you or anyone else comment on what the difference if any in TheraSphere and SIR-Spheres and does Sirtex have any IP/Patent protection for its technology?
SRX Price at posting:
$15.01 Sentiment: Hold Disclosure: Held
